Regulating the anticancer drug release rate by controlling the composition of waterborne polyurethane

Tailoring of an anti-diabetic drug empagliflozin onto zinc oxide nanoparticles: characterization and in vitro evaluation of anti-hyperglycemic potential

Diabetes is a serious health issue that can be a great risk factor related to numerous physical problems. A class of drugs "Gliflozin" especially Sodium Glucose Co. Transporter 2 was inhibited by a novel drug, which is known as "empagliflozin". While ZnO nanoparticles (NPs) had considerable promise for combating diabetes, it was employed in the treatment and management of type-2 diabetes mellitus. The new drug empagliflozin was initially incorporated into Zinc Oxide NPs in this study using the surface physio-sorption technique, and the degree of drug adsorption was assessed using the HPLC method. The tailored product was characterized by using the FTIR, EDX, Ultraviolet-Visible, XRD and SEM techniques. With an average particle size of 17 nm, SEM revealed mono-dispersion of NPs and sphere-like form. The Freundlich isotherm model best fits and explains the data for the physio-sorption investigation, which examined adsorption capabilities using adsorption isotherms. The enzymes α-amylase and α-glucosidase, which are involved in the human metabolism of carbohydrates, were used in the in-vitro anti-diabetic assays. It was discovered that the composite showed the highest levels of 81.72 and 92.77% inhibition of -α-amylase and -glucosidase at an absolute concentration of 1000 μg per ml with IC50 values of 30.6 μg per ml and 72 μg per ml.

Development of amylopectin based polyurethanes for sustained drug release studies

In this research work, the crosslinked structure of polyurethane has been exploited for sustained drug delivery. Polyurethane composites have been prepared by the reaction of isophorone diisocyanate (IPDI) and polycaprolactone diol (PCL), which were further extended by varying the mole ratios of amylopectin (AMP) and 1,4-butane diol (1,4-BDO) chain extenders. The progress and completion of the reaction of polyurethane (PU) were confirmed using Fourier Transform infrared (FTIR) and nuclear magnetic resonance (¹H NMR) spectroscopic techniques. Gel permeation chromatography (GPC) analysis showed that the molecular weights of prepared polymers were increased with the addition of amylopectin into the PU matrix. The molecular weight of AS-4 (M_w ≈ 99,367) was found threefold as compared to amylopectin-free PU (M_w ≈ 37,968). Thermal degradation analysis was done using thermal gravimetric analysis (TGA) and inferred that AS-5 showed stability up to 600 °C which was the maximum among all PUs because AMP has a large number of -OH units for linking with prepolymer resulting in a more cross-linked structure which improved the thermal stability of the AS-5 sample. The samples prepared with AMP showed less drug release (<53 %) as compared to the PU sample prepared without AMP (AS-1).

Biomedical Polyurethanes for Anti-Cancer Drug Delivery Systems: A Brief, Comprehensive Review

With the intensive development of polymeric biomaterials in recent years, research using drug delivery systems (DDSs) has become an essential strategy for cancer therapy. Various DDSs are expected to have more advantages in anti-neoplastic effects, including easy preparation, high pharmacology efficiency, low toxicity, tumor-targeting ability, and high drug-controlled release. Polyurethanes (PUs) are a very important kind of polymers widely used in medicine, pharmacy, and biomaterial engineering. Biodegradable and non-biodegradable PUs are a significant group of these biomaterials. PUs can be synthesized by adequately selecting building blocks (a polyol, a di- or multi-isocyanate, and a chain extender) with suitable physicochemical and biological properties for applications in anti-cancer DDSs technology. Currently, there are few comprehensive reports on a summary of polyurethane DDSs (PU-DDSs) applied for tumor therapy. This study reviewed state-of-the-art PUs designed for anti-cancer PU-DDSs. We studied successful applications and prospects for further development of effective methods for obtaining PUs as biomaterials for oncology.

Controlled preparation of grafted starch modified with Ni nanoparticles for biodegradable polymer nanocomposites and its application in food packaging

Grafting of starch with methyl methacrylate was carried out using a free radical mechanism. Free radicals were generated by the thermal disintegration of potassium persulphate at the temperature of 60°C. A variety of experimental methods were investigated to check the effect of different parameters such as (temperature, amount of starch, quantity of monomer) for efficient grafting. The optimum temperature found for good grafting was 60°C. The initial amount of starch was taken as 0.75 g. Keeping the amount of starch constant, the quantity of monomer was reduced gradually from 10 to 2 ml in portions of 5 and 3 ml. The controlled biodegradability of the grafted product was obtained by using a 3 ml monomer in 0.75 g starch. This grafted polymer showed 31.45% biodegradability in 60 days. The nanocomposite of starch grafted methyl methacrylate was prepared by incorporating 0.02 g Ni nanoparticles in the reaction flask 15 min before the completion of reaction time. The starch grafted polymer and nanocomposite of this were fully characterized by SEM, FTIR, TGA, and DSC techniques. The soil burial method was applied to estimate the biodegradability of samples. The polymer containing Ni nanoparticles was less biodegradable than without nanoparticles. Such polymers can be efficiently used as packaging material for food items.

Synthesis, carbonic anhydrase enzyme inhibition evaluations, and anticancer studies of sulfonamide based thiadiazole derivatives

The sulfonamide-based thiadiazole derivatives (STDs) with different hydrophobic/hydrophilic substitutions were synthesized to investigate their potentials in carbonic anhydrase inhibition (CAI). The CAI activity of the STDs (4a-4h) and the mechanism of the inhibition kinetics were determined. STD 4f contained both methoxy and Cl groups at benzene ring in STD 4f showed the lowest IC₅₀ value. The molecular docking study confirmed that STDs bind strongly with the active sites of the target protein PDBID 1V9E. With the help of Lineweaver-Burk plots, inhibition kinetics of PDBIR 1V9E protein with STDs were determined. Cytotoxicity was checked against human keratinocyte cell lines and the anticancer properties were determined against MCF-7 cell lines. The electrochemical method was used to investigate the binding study with DNA and CA enzymes. Anticancer studies showed that STDs have weak bonding ability to DNA and strong binding ability with CA. It is concluded that anticancer activity is through CAI rather than by DNA binding.

Thermal degradation study of polymethylmethacrylate with AlI3 nanoadditive

Organic polymers in the process of thermal degradation produce a lot of toxic fragments. In this work, we designed a new method of degradation of polymethylmethacrylate (PMMA) materials with aluminum triiodide nanoadditives (AlI₃ NAs). In the present research work, a thermal degradation study of PMMA blends with AlI₃ NAs was carried out by using a specially designed pyrolytic assembly. Different blends of PMMA with AlI₃ (P0, P3, P6, P9, P12, and P15) were prepared by changing the concentration of AlI₃ NAs from 0% to 15%. FTIR and TGA studies show the stability of polymers with AlI₃ NAs. Scanning electron microscopy analysis shows All₃ spread uniformly at nanoscale throughout the polymer matrix. Horizontal burning test (HBT) test confirms that polymer burning is retarded with AlI₃ NAs.

The Effect of AlI3 Nanoadditive on the Thermal Behavior of PMMA Subjected to Thermoanalytical Py-GC-MS Technique

Thermal degradation of polymethylmethacrylate (PMMA) was studied by using inorganic salt of aluminum triiodide (AlI3). The composites of PMMA were prepared with AlI3 by changing the concentration of the AlI3 additive from 2% to 10% (w/w). The PMMA composites with AlI3 were characterized by TGA, DTG, SEM, FTIR, HBT, and Py-GC-MS techniques. The FTIR peaks of PMMA composite at 1316, 786, and 693 cm-1 justify the chemical association between PMMA and AlI3. TGA study shows that the stability of PMMA is enhanced by the addition of the AlI3 additive. SEM analysis represented that there is a relationship between polymer and additive when they are mixed at the molecular level. The horizontal burning test (HBT) also confirmed that the AlI3 additive produced the flame retarding properties in PMMA polymer. The burning rate of composite with 10% of AlI3 additive decreases five times as much as compared to pure PMMA polymer. Py-GC-MS analysis deduced that PMMA composite produced less toxic and environment-friendly substances (CO2) by the influence of AlI3 additive as compared to neat PMMA.

Polymeric drug delivery systems by additive manufacturing

Additive manufacturing (AM) is gaining interests in drug delivery applications, offering innovative opportunities for the design and development of systems with complex geometry and programmed controlled release profile. In addition, polymer-based drug delivery systems can improve drug safety, efficacy, patient compliance, and are the key materials in AM. Therefore, combining AM and polymers can be beneficial to overcome the existing limitations in the development of controlled release drug delivery systems. Considering these advantages, here we are focusing on the recent developments in the field of polymeric drug delivery systems prepared by AM. This review provides a comprehensive overview on a holistic polymer-AM perspective for drug delivery systems with discussion on the materials, properties, design and fabrication techniques and the mechanisms used to achieve a controlled release system. The current challenges and future perspectives for personalized medicine and clinical use of these systems are also briefly discussed.

Effect of organic solvents on solvatochromic, fluorescence, and electrochemical properties of synthesized thiazolylcoumarin derivatives

In this present investigation, thiazolylcoumarin derivatives (5a-5k) were synthesized from thiosemicarbazide, ethyl acetoacetate, and naphthaldehyde through a multistep route. The formation of thiazolylcoumarin derivatives with bioactive scaffolds was confirmed through nuclear magnetic resonance spectroscopy. A solvatochromic study of synthesized thiazolylcoumarin derivatives was carried out using ultraviolet-visible methods for dimethylformamide (DMF), ethyl acetate, and ethanol solvents. The redox behaviour of as-synthesized thiazolylcoumarin derivatives (5a-5k) was examined in dimethyl sulphoxide by conducting an electrochemical study. Fluorescence properties of thiazolylcoumarin derivatives were studied in DMF, ethanol, and ethyl acetate to visualize the solvent effect on the emitting ability of thiazolylcoumarin derivatives.

Waterborne poly(urethane-urea)s films as a sustained release system for ketoconazole

Ketoconazole (KTZ) was incorporated in waterborne poly(urethane-urea)s dispersions (WPUU), aiming at the production of films for drug sustained release. Dispersions based on poly(ethylene glycol-block-propylene glycol) (PEG-b-PPG) (four monomers with different contents of PEG hydrophilic segments), poly(propylene glycol), isophorone diisocyanate, dime-thylolpropionic acid and hydrazine were produced and characterized by apparent viscosity and average particle size (APS). Cast films-drug interaction was investigated by Fourier-Transform infrared spectrometry (FTIR). In vitro dissolution assays were performed in simulated gastrointestinal juices, followed by application of kinetic models. Stable pseudoplastic dispersions, with APS between 27 to 320 nm were obtained. FTIR from KTZ-loaded films indicated interactions between polymer and drug. In vitro release of KTZ was achieved above 80%, notably influenced by PEG-based segments content up to 2 h, followed by sustained release for 8 h. Higuchi’s and first-order equations described the drug kinetic profile, as diffusion of the drug and erosion of the swollen polymer, respectively.